IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Leukemia Research- Impact Score, Overall Ranking, h-index, SJR, Rating, Publisher, ISSN, and Other Important Metrics

Last Updated on May 27, 2022

Impact Score

2.40

h-Index

 90

Rank

 5097

SJR

 0.865

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics

Title Leukemia Research
Abbreviation Leuk. Res.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q2); Hematology (Q2); Oncology (Q2)
h-index 90
Overall Rank/Ranking 5097
SCImago Journal Rank (SJR) 0.865
Impact Score 2.40
Publisher Elsevier Ltd.
Country United Kingdom
ISSN 18735835, 01452126




Aim and Scope


Leukemia Research is an international journal which brings comprehensive and current information to all health care professionals involved in basic and (or) applied clinical research in leukemias, lymphomas, multiple myeloma and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology and molecular biology as well as epidemiologic and clinical studies.


About Leukemia Research


Leukemia Research is a journal covering the technologies/fields/categories related to Cancer Research (Q2); Hematology (Q2); Oncology (Q2). It is published by Elsevier Ltd.. The overall rank of Leukemia Research is 5097. According to SCImago Journal Rank (SJR), this journal is ranked 0.865. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 90. The best quartile for this journal is Q2.

The ISSN of Leukemia Research journal is 18735835, 01452126. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Leukemia Research is cited by a total of 1170 articles during the last 3 years (Preceding 2021).


Leukemia Research Impact Score 2021-2022


The impact score (IS) 2021 of Leukemia Research is 2.40, which is computed in 2022 as per its definition. Leukemia Research IS is increased by a factor of 0.32 and approximate percentage change is 15.38% when compared to preceding year 2020, which shows a rising trend. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Leukemia Research Impact Score 2022 Prediction


IS 2021 of Leukemia Research is 2.40. If the same upward trend persists, impact score may rise in 2022 as well.


Impact Score Trend


Year wise Impact Score (IS) of Leukemia Research. Based on Scopus data.


Year Impact Score (IS)
2022/2023 Coming Soon
2021 2.40
2020 2.08
2019 2.02
2018 1.96
2017 2.20
2016 2.46
2015 2.53
2014 2.05

Leukemia Research h-index


  Table Setting

Leukemia Research has an h-index of 90. It means 90 articles of this journal have more than 90 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Leukemia Research ISSN


The ISSN of Leukemia Research is 18735835, 01452126. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Leukemia Research Rank and SCImago Journal Rank (SJR)


The overall rank of Leukemia Research is 5097. According to SCImago Journal Rank (SJR), this journal is ranked 0.865. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Leukemia Research Publisher


Table Setting

Leukemia Research is published by Elsevier Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1977-2021. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Leukemia Research is Leuk. Res.. This abbreviation ('Leuk. Res.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Leukemia Research


If your research field is/are related to Cancer Research (Q2); Hematology (Q2); Oncology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Review of Contemporary Philosophy journal 12552 Addleton Academic Publishers 12 4.80
Applied Mathematics and Optimization journal 3829 Springer New York 48 2.23
Journal of Electronic Science and Technology journal 13647 University of Electronic Science and Technology of China 8 2.89
NWIG New West Indian Guide journal 23147 Brill Academic Publishers 6 0.18
Politics and Religion journal 9155 Cambridge University Press 20 1.38
Pure and Applied Mathematics Quarterly journal 13226 International Press of Boston, Inc. 23 0.42
Frontiers in Integrative Neuroscience journal 4744 Frontiers Media S.A. 65 2.94
Applied Rheology journal 18165 Kerschensteiner Verlag GmbH 31 1.26
Mass Spectrometry Reviews journal 1160 John Wiley & Sons Inc. 130 10.95
AI Magazine journal 8614 AI Access Foundation 79 2.87

Check complete list




Year wise Impact Score (IS) of Leukemia Research

Impact Score Table

Year Impact Score (IS)
2022/2023 Coming Soon
2021 2.40
2020 2.08
2019 2.02
2018 1.96
2017 2.20
2016 2.46
2015 2.53
2014 2.05



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Journal for ImmunoTherapy of Cancer
BioMed Central Ltd. | United Kingdom

See All

Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Blood
American Society of Hematology | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Leukemia
Nature Publishing Group | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Haematologica
Ferrata Storti Foundation | Italy

Blood advances
American Society of Hematology | United States

Blood Reviews
Churchill Livingstone | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Lancet Oncology, The
Lancet Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Journal of Clinical Oncology
American Society of Clinical Oncology | United States

JAMA Oncology
American Medical Association | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Cancer Discovery
American Association for Cancer Research Inc. | United States

See All